A Study to Develop and Validate a Device for Continuous Blood Flow Lactate Monitoring
Overview
Tab Title Description
Study type
InterventionalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Scottsdale/Phoenix, Arizona: 14-008935
Sponsor Protocol Number: 14-008935
About this study
The purpose of this study is to use patient blood and blood data to help develop and then validate a device to continuously monitor blood levels of lactate in the critically ill.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria
- Clinical blood samples obtained from patients in the Intensive Care Unit of Mayo Clinic Arizona
- Only those patients who are having a lactate drawn for clinical management purposes will be included in the study
- Informed consent for the study will be obtained from the patients or their surrogate
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Scottsdale/Phoenix, Ariz.
Mayo Clinic principal investigator Ayan Sen, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available